21 May 2013
Keywords: gene, bridges, licenses, red/et, novozymes, german, firm
Article | 05 May 2008
German firm Gene Bridges has completed a commercial license agreement with Danish biosolutions provider Novozymes, for the use of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
12 May 2008
20 May 2013
© 2013 thepharmaletter.com